Cerus Announces Deal with Swiss Red Cross for Initial Deployment of INTERCEPT Blood System

Cerus Corporation

announced today that it has signed a two-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma in Lausanne and Zurich. These two pilot centers supply an estimated 15,000 plasma units annually.